Abstract

HLA-G: A Versatile Biomarker

HLA-G is a non-classical MHC Class I molecule that is usually restricted to cytotrophoblasts and other fetal cells in order to protect the fetus from maternal immune responses. However, HLA-G is expressed during viral infections and cancer. The presence of soluble HLA-G, sHLA-G, in serum is noted in various instances of human diseases. Serum HLA-G can serve as a biomarker, which makes it a unique tool in developing confirmatory diagnostics for infectious diseases and cancer. An accurate and early diagnosis of deadly diseases is really important for an early intervention or treatment. The immunosuppressive capabilities of HLA-G make it not only a biomarker for diagnosis but also an excellent target for developing therapeutics. Here, I discuss HLA-G’s potential to be an invaluable tool as a biomarker for diagnostics and a target for therapeutics.


Author(s):

Mugdha Vasireddi



Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+

Recommended Conferences

  • 12th World Congress on Biomarkers & Clinical Research
    October 03-04, California, USA
  • 22nd World Conference on Liquid Biopsy & Biomarkers
    October 15-16, Toronto, Canada
  • International Conference And Expo On Biomarkers and Genomic Medicine 2018
    October 29-30, Osaka, Japan
Flyer image

Abstracted/Indexed in

  • Index Copernicus
  • Google Scholar
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research